Which stock is cheaper: CIPLA or LAURUSLABS?

Based on Price to Earnings, CIPLA trades at a P/E of 32.3 while LAURUSLABS trades at a P/E of 98.1.

Does CIPLA or LAURUSLABS have higher ROCE?

CIPLA generates an ROCE of 15.9% compared to LAURUSLABS's ROCE of 22.9%.

CIPLA LTD (CIPLA) has a market cap of ₹1,10,353 Cr compared to LAURUS LABS LIMITED (LAURUSLABS) with ₹1,06,387 Cr.

CIPLAHealthcare

₹1,378.90+1.54%

Market Cap: ₹1,10,353 Cr

Leads (3/5)

₹2,405.50+7.20%

Market Cap: ₹1,06,387 Cr

Automated quantitative breakdown of fundamental strengths between CIPLA and LAURUSLABS.

Attractive ValuationCIPLA (P/E 32.3)Trades at lower Price-to-Earnings

Capital EfficiencyLAURUSLABS (ROCE 22.9%)Superior operating return on capital

Balance Sheet SafetyCIPLALower debt-to-equity ratio

Shareholder YieldLAURUSLABS (12.00%)Higher annual dividend yield

Green highlight indicates the stronger metric

Financial Metric	CIPLA	LAURUSLABS
Valuation Multiples
Market Capitalization	₹1,10,353 Cr	₹1,06,387 Cr
Price to Earnings (P/E)	32.32	98.07
Price to Book (P/B)	3.23	20.26
Profitability & Capital Efficiency
Return on Capital Employed (ROCE)	15.89%	22.85%
Return on Equity (ROE)	11.12%	9.46%
Operating Profit Margin (OPM)	16.22%	22.01%
Net Profit Margin (NPM)	23.17%	13.78%
Balance Sheet & Solvency
Debt to Equity Ratio	0.00	0.40
Dividend Yield	6.82%	12.00%
Historical Growth
3-Year Sales Growth (CAGR)	1.84%	22.60%
Latest Quarter Financial Results
Quarterly Revenue (30 Jun 2026)	₹7,077 Cr	₹2,026 Cr
Quarterly Net Profit	₹789 Cr	₹368 Cr